The 74 references in paper T. Geliashvili M., A. Vazhenin V., N. Afanas’eva G., Т. Гелиашвили М., А. Важенин В., Н. Афанасьева Г. (2017) “Основы применения совмещенной позитронно-эмиссионной и компьютерной томографии с 18-фтордезоксиглюкозой при дифференцированном раке щитовидной железы после первичного лечения // The use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in patients with differentiated thyroid cancer after initial treatment” / spz:neicon:ogsh:y:2017:i:1:p:12-21

1
ПЭТ / КТ составила 78, 85 и 93 % соответственно [56].
(check this in PDF content)
2
Заключение Показания к применению ПЭТ / КТ в онкологии расширяются во всем мире. И, несмотря на возможности многочисленных новых трейсеров, ФДГ остается наибо
(check this in PDF content)
3
DOI: 10.1210/jc.2005-2838.
(check this in PDF content)
4
PMID: 16684830 19. Валдина Е.А. Заболевания щитовидной железы: Руководство. СПб.: Питер, 2006. [Valdina E.A. Thyroid disorders. Guidelines. Saint-Petersburg: Piter, 2006. (In Rus
(check this in PDF content)
5
PMID: 8410272 22. Schlumberger M.J., Arcangioli O., Piekarski J.D. et
(check this in PDF content)
6
PMID: 3183748 23. King A.D. Imaging for staging and management of thyroid cancer. Cancer Imaging 2008;8:57–
(check this in PDF content)
7
DOI: 10.1102/1470-7330.2008.0007.
(check this in PDF content)
8
PMID: 18390389 24. Kucuk O.N., Gultekin S.S., Aras G., Ibis E.
(check this in PDF content)
9
PMID: 16479246 25. Dietlein M., Scheidhauer K., Voth E. et al. Fluorine-18 fluorodeoxyglucose positron emission tomograph
(check this in PDF content)
10
PMID: 9371865 26. Salvatori M., Biondi B., Rufini V. Imaging in endocrinology: 2-[18F]-fluoro-2deoxy-D-glucose positron emission tomogra
(check this in PDF content)
11
DOI: 10.1530/EJE-15-0066.
(check this in PDF content)
12
PMID: 25947140 27. Leboulleux S., Schroeder P.R., Busaidy N.L. et al. Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-fluoro-2-
(check this in PDF content)
13
Endocrinol Metab 2009;94(4):1310–6.
(check this in PDF content)
14
DOI: 10.1210/jc.2008-1747.
(check this in PDF content)
15
PMID: 19158200 28. Padovani R.P., Robenshtok E., Brokhin M., Tuttle R.M.
(check this in PDF content)
16
DOI: 10.1089/thy.2011.0522.
(check this in PDF content)
17
PMID: 22780333 29. Tuttle R.M., Tala H., Shah J. et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive io
(check this in PDF content)
18
American Thyroid Association staging system. Thyroid 2010;20(12):1341–9.
(check this in PDF content)
19
DOI: 10.1089/thy.2010.0178. 30. Cooper D.S., Doherty G.M., Haugen B.R. et al. Revised American Thyroid Association management gu
(check this in PDF content)
20
DOI: 10.1089/thy.2009.0110.
(check this in PDF content)
21
PMID: 19860577 31. Treglia G., Bertagna F., Piccardo A., Giovanella L.
(check this in PDF content)
22
DOI: 10.1007/s40336-013-0024-0. 32. Leboulleux S., El Bez I., Borget I. et al. Postradioiodine treatment whole body
(check this in PDF content)
23
DOI: 10.1089/thy.2012.0081. 33. Dong M.J., Liu Z.F., Zhao K. et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-n
(check this in PDF content)
24
DOI: 10.1097/MNM.0b013e32832dcfa7.
(check this in PDF content)
25
PMID: 19512954 34. Kim W.G., Ryu J.S., Kim E.Y. et al. Empiric high-dose 131-Iodine therapy lacks efficacy for treated papillary
(check this in PDF content)
26
Endocrinol Metab 2010;95(3):1169–73.
(check this in PDF content)
27
DOI: 10.1210/jc.2009-1567. 35. Giovanella L. Positron emission tomography/computed tomography in patients treated for differentiated thyroid carcinomas. Exp Rev Endocr
(check this in PDF content)
28
DOI: 10.1586/eem.11.83. 36. Pacak K., Eisenhofer G., Goldstein D.S. Functional imaging of endocrine tumors: role of positron emission
(check this in PDF content)
29
Endocr Rev 2004;25(4):568–80.
(check this in PDF content)
30
DOI: 10.1210/er.2003-0032.
(check this in PDF content)
31
PMID: 15294882 37. Robbins R.J., Wan Q., Grewal R.K. et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]f
(check this in PDF content)
32
DOI: 10.1210/jc.2005-1534.
(check this in PDF content)
33
PMID: 16303836 38. Deandreis D., Al Ghuzlan A., Leboulleux S. et al. Do histological, immunohistochemical and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thy
(check this in PDF content)
34
DOI: 10.1677/ERC-10-0233. 39. Wang W., Larson S.M., Fazzari M. et al. Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scan
(check this in PDF content)
35
DOI: 10.1210/jcem.85.3.6458.
(check this in PDF content)
36
PMID: 10720047 40. Pryma D.A., Schoder H., Gonen M. Diagnostic accuracy and prognostic value of 18F-FDG PET in
(check this in PDF content)
37
PMID: 16883003 41. Rosenbaum-Krumme S.J., Gorges R., Bockisch A., Binse I.
(check this in PDF content)
38
DTC after first radioiodine therapy.
(check this in PDF content)
39
Eur J Nucl Med Mol Imaging 2012;39(9):1373–80.
(check this in PDF content)
40
DOI: 10.1007/s00259-012-2065-4.
(check this in PDF content)
41
PMID: 22718304 42. Gaertner F.C., Okamoto S., Shiga T. et al.
(check this in PDF content)
42
FDG PET performed at thyroid remnant ablation has a higher predictive value for long-term survival of high-risk patients with well-differentiated thyroid cancer than radioiodine uptake
(check this in PDF content)
43
DOI: 10.1097/RLU.0000000000000699.
(check this in PDF content)
44
PMID: 25608175 43. Sisson J.C., Ackermann R.J., Meyer M.A., Wahl R.L.
(check this in PDF content)
45
Endocrinol Metab 1993;77(4):1090–4.
(check this in PDF content)
46
DOI: 10.1210/jcem.77.4.8408458.
(check this in PDF content)
47
PMID: 8408458 44. van Tol K.M., Jager P.L., Piers D.A. et al. Better yield of (18)fluorodeoxyglucosepositron emission t
(check this in PDF content)
48
DOI: 10.1089/105072502760043459.
(check this in PDF content)
49
PMID: 12097198 45. Grunwald F., Biersack H.J. FDG PET in thyroid cancer: thyroxine or not? J Nucl Med 2000;41(12):1996–8.
(check this in PDF content)
50
PMID: 11138684 46. Marcus C., Whitworth P.W., Surasi D.S. et al. PET/CT in the management of thyroid canc
(check this in PDF content)
51
DOI: 10.2214/AJR.13.11673. 47. Vural G.U., Akkas B.E., Ercakmak N. et al. Prognostic significance of FDG
(check this in PDF content)
52
PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlat
(check this in PDF content)
53
DOI: 10.1097/RLU.0b013e31825b2057.
(check this in PDF content)
54
PMID: 22899202 48. Zoller M., Kohlfuerst S., Igerc I. et al.
(check this in PDF content)
55
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? Eur J Nucl
(check this in PDF content)
56
Med Mol Imaging 2007;34(4):487–95.
(check this in PDF content)
57
DOI: 10.1007/s00259-006-0276-2.
(check this in PDF content)
58
PMID: 17103166 49. Bertagna F., Bosio G., Biasiotto G. et al. F-18 FDGPET/CT evaluation of patients with differentiated thyroid cancer with nega
(check this in PDF content)
59
DOI: 10.1097/RLU.0b013e3181b7d95c.
(check this in PDF content)
60
PMID: 19851169 50. Schluter B., Bohuslavizki K.H., Beyer W. et al. Impact of FDG PET on patients with differentiated thyroid cancer who pr
(check this in PDF content)
61
PMID: 11197983 51. Shammas A., Degirmenci B., Mountz J.M. et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic welldifferentiated thyroid cancer. J Nucl
(check this in PDF content)
62
PMID: 17268018 52. Bertagna F., Biasiotto G., Orlando E. et al. Role of 18F-fluorodeoxyglucose positron emission tomography/computed
(check this in PDF content)
63
Jpn J Radiol 2010;28(9):629–36.
(check this in PDF content)
64
DOI: 10.1007/s11604-010-0488-z. 53. Zimmer L.A., McCook B., Meltzer C. et al. Combined positron emission tomography/computed tomography imaging of recurre
(check this in PDF content)
65
Otolaryngol Head Neck Surg 2003;128(2):178–84.
(check this in PDF content)
66
DOI: 10.1067/mhn.2003.74.
(check this in PDF content)
67
PMID: 12601311 54. Giovanella L., Trimboli P., Verburg F.A. et al. Thyroglobulin levels and thyroglobulin doubling time independently
(check this in PDF content)
68
Med Mol Imaging 2013;40(6):874–80.
(check this in PDF content)
69
DOI: 10.1007/s00259-013-2370-6.
(check this in PDF content)
70
PMID: 2346330 55. Nanni C., Rubello D., Fanti S. et al. Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. Biomed Pharmacother 2006;60(8):409–13.
(check this in PDF content)
71
DOI: 10.1016/j.biopha.2006.07.008.
(check this in PDF content)
72
PMID: 16891093 56. Palmedo H., Bucerius J., Joe A. et al.
(check this in PDF content)
73
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 2006;47(4):616–24.
(check this in PDF content)
74
PMID: 16595495
(check this in PDF content)